home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

442.16 -1.76 (-0.40%)

Streaming Delayed Price Updated: 2:32 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

72 73 Next >

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗

February 23, 2024

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Via Investor's Business Daily

The Best Stocks to Invest $5,000 in Right Now ↗

February 23, 2024

These stocks could be huge winners for long-term investors.

Via The Motley Fool

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗

February 22, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

Via InvestorPlace

3 Secret Stocks to Double Your Money by 2028 ↗

February 22, 2024

Vertex Pharmaceuticals (VRTX), UiPath (PATH), and Science Applications International (SAIC) are 3 secret stocks to double your money by 2028.

Via InvestorPlace

Vertex to Participate in Upcoming Investor Conferences

February 20, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

What Analysts Are Saying About Vertex Pharmaceuticals Stock ↗

February 20, 2024

Via Benzinga

Stock-Split Watch: Is Vertex Pharmaceuticals Next? ↗

February 14, 2024

It's on track to launch more blockbuster drugs.

Via The Motley Fool

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market ↗

February 20, 2024

Vertex's main business may be heading for a new era of growth...

Via The Motley Fool

Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought ↗

February 20, 2024

These exciting players could deliver explosive growth over time.

Via The Motley Fool

3 Revolutionary Biotech Stocks Poised for 10X Surge ↗

February 19, 2024

Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.

Via InvestorPlace

3 Magnificent Growth Stocks to Buy Right Now ↗

February 19, 2024

These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.

Via The Motley Fool

Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market? ↗

February 18, 2024

The pain market is in great need of new options.

Via The Motley Fool

2 Top Growth Stocks to Buy With $1,000 Right Now ↗

February 18, 2024

Even a modest starting investment in the right stocks could pay off in the years ahead.

Via The Motley Fool

Could Vertex Pharmaceuticals Reach $500 in 2024? ↗

February 10, 2024

Vertex shares have several catalysts on the horizon...

Via The Motley Fool

Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move. ↗

February 17, 2024

Sometimes, the winning move doesn't look right at first.

Via The Motley Fool

2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now ↗

February 17, 2024

The healthcare industry often remains resilient amid macro headwinds, and these two stocks are prime examples.

Via The Motley Fool

Giving Uber Its Due ↗

February 15, 2024

We've also got a look at good news from Chipotle and Roblox, and we put some stocks on a dating show.

Via The Motley Fool

Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. ↗

February 15, 2024

These stocks have what it takes to drive superior returns in the years to come.

Via The Motley Fool

Gene therapy: Why does it cost millions for a single treatment?

February 15, 2024

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.

Via MarketBeat

Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x? ↗

February 15, 2024

There's more to consider with Vertex's valuation than one number.

Via The Motley Fool

If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today ↗

February 13, 2024

You can't go back in the past, but it's not too late to invest in this top stock.

Via The Motley Fool

European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

February 13, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

2 Healthcare Stocks That Could Help Set You Up for Life ↗

February 12, 2024

These rock-solid businesses can add meaningful returns to a long-term portfolio.

Via The Motley Fool

3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗

February 11, 2024

Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.

Via InvestorPlace

Is Vertex Pharmaceuticals Stock a Buy Now? ↗

February 10, 2024

The company just released its latest earnings report, and growth investors may be a little disappointed.

Via The Motley Fool

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

February 10, 2024

These businesses are built to last.

Via The Motley Fool

2 No-Brainer Healthcare Stocks to Buy Right Now ↗

February 10, 2024

Companies in the healthcare industry tend to generate returns in a wide range of market environments.

Via The Motley Fool

3 Stocks That Could Trounce the Market in 2024 ↗

February 10, 2024

These stocks appear to have what it takes to beat the market this year.

Via The Motley Fool

3 Growth Stocks With More Potential Than Any Cryptocurrency ↗

February 09, 2024

The stock market is full of opportunities for investors of all risk appetites and trading styles.

Via The Motley Fool

3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List ↗

February 09, 2024

These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.

Via InvestorPlace

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com